Early onset type 2 diabetes mellitus: an update
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The incidence and prevalence of type 2 diabetes mellitus (T2DM) in young individuals (aged <40 years) have significantly increased in recent years, approximating two to threefold increase in the respective rates. Numerous risk factors including severe obesity, family history, ethnicity, maternal diabetes or gestational diabetes, and female sex contribute to a younger age of onset. In terms of pathogenesis, impaired insulin secretion is the key operating mechanism, alongside with ectopic adiposity-related insulin resistance. T2DM diagnosis in a young adult requires the exclusion of type 1 diabetes mellitus (T1DM), latent autoimmune diabetes of adults (LADA) and maturity-onset diabetes of the young (MODY). The establishment of such diagnosis is critical for prognosis, because early-onset T2DM is associated with rapid deterioration in pancreatic β-cell secretory function leading to earlier initiation of insulin therapy. Furthermore, mortality and lifetime risk of developing complications, especially microvascular, is increased in these patients compared to both later-onset T2DM and T1DM patients; also, the latter are often developed earlier in the course of disease. The management of early-onset T2DM follows the same guidelines as in later-onset T2DM; yet patients aged 18–39 years are underrepresented in the big clinical trials on which the development of guidelines is based. Finally, young people with T2DM face significant challenges associated with social determinants, which compromise their adherence to therapy and induce diabetes distress. Future research focusing on the pathogenesis of β-cell decline and complications, as well as on specific treatment shall lead to better understanding and management of early-onset T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this context, AI and machine learning–based predictive models, which can outperform traditional scores for predicting incident T2D and its complications, are likely to yield greater lifetime benefit in EOT2D than in usual-onset T2D by enabling earlier identification of high-risk trajectories and more aggressive preventive care over several decades of disease [55, 57, 58].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [57]
In the citing paper
“Similarly, youth-onset cohorts such as TODAY/TODAY2 showed that by a mean diabetes duration of 13 years (early adulthood), up to 60% of participants develop at least one microvascular complication, and many have multiple complications, underscoring the need for early, intensive, and precisely targeted intervention in this vulnerable group [55, 57–59].”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“…loss of ≥ 15 kg in 24% and T2DM remission in 46% of participants in the intervention group (vs. 0% and 4% in control group who was treated according to guidelines), suggesting that T2DM can be reversed if appropriate dietary and lifestyle interventions are applied shortly after diagnosis [71].”
BackgroundEctopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126 · cited 1×
“Similarly, in liver, there is inhibition of glycogen synthase activity and stimulation of gluconeogenic enzymes expression, leading to attenuated glycogenesis and enhanced gluconeogenesis [21].”
BackgroundLean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 1×
“…tyrosine phosphorylation and hence of the following phosphatidylinositol 3 kinase activity and glucose transporter 4 transportation to the cell surface, resulting into decreased glucose uptake and glycogenesis, which is actually considered as the primary metabolic defect in T2DM pathogenesis [20].”
BackgroundType 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824 · cited 10×
“Early-onset T2DM is strongly associated with obesity, metabolic syndrome features, insulin resistance, family history, and necessitates faster progression to insulin therapy, i.e., in 2 – 5 years after diagnosis in >50% of patients [2].”
BackgroundResultInfluentialA practical review of C-peptide testing in diabetes
Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0265-4 · Cited by 773 · cited 1×
“…vary among individuals with autoimmune diabetes, by the time that full-blown picture of insulinopenia is established, plasma C-peptide level is usually undetectable and may be used to differentiate immune-mediated diabetes from other DM types [44, 45], except from the honeymoon phase of LADA.”
BackgroundThe global spread of type 2 diabetes mellitus in children and adolescents
Pinhas-Hamiel, O., & Zeitler, P. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.042 · Cited by 652
Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Long-term complications in youth-onset type 2 diabetes
TODAY Study Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100165 · Cited by 546 · cited 1×
“Complications examined included hypertension, dyslipidemia, and microvascular complications such as neuro-pathy, nephropathy, and retinopathy [50].”
Background
Research works printed but not linked: 61
- International Diabetes Federation. IDF Diabetes Atlas 10th Edition, 2021. https://diabetesatlas.org/
- W. Perng, R. Conway, E. Mayer-Davis, D. Dabelea, Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care 46, 490–499 (2023). https://doi.org/10.2337/dci22-0046 · DOI · Paper page
- E.J. Mayer-Davis, J.M. Lawrence, D. Dabelea, J. Divers, S. Isom, L. Dolan, G. Imperatore, B. Linder, S. Marcovina, D.J. Pettitt, C. Pihoker, S. Saydah, L. Wagenknecht, Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N. Engl. J. Med. 376, 1419–1429 (2017). https://doi.org/10.1056/NEJMoa1610187 · DOI · Paper page
- D. Dabelea, E.J. Mayer-Davis, S. Saydah, G. Imperatore, B. Linder, J. Divers, R. Bell, A. Badaru, J.W. Talton, T. Crume, A.D. Liese, A.T. Merchant, J.M. Lawrence, K. Reynolds, L. Dolan, L.L. Liu, R.F. Hamman, Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311, 1778 (2014). https://doi.org/10.1001/jama.2014.3201 · DOI · Paper page
- S.E. Holden, A.H. Barnett, J.R. Peters, S. Jenkins-Jones, C.D. Poole, C.L. Morgan, C.J. Currie, The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes. Metab. 15, 844–852 (2013). https://doi.org/10.1111/dom.12123 · DOI · Paper page
- N. Lascar, Q.-A. Altaf, N.T. Raymond, J. E. P. Brown, H. Pattison, A. Barnett, C.J. Bailey, S. Bellary, Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. Curr. Med. Res. Opin. 35, 1893–1900 (2019). https://doi.org/10.1080/03007995.2019.1638239 · DOI · Paper page
- E.K. Sims, R.E.J. Besser, C. Dayan, C. Geno Rasmussen, C. Greenbaum, K.J. Griffin, W. Hagopian, M. Knip, A.E. Long, F. Martin, C. Mathieu, M. Rewers, A.K. Steck, J.M. Wentworth, S.S. Rich, O. Kordonouri, A.-G. Ziegler, K.C. Herold, Screening for type 1 diabetes in the general population: a status report and perspective. Diabetes 71, 610–623 (2022). https://doi.org/10.2337/dbi20-0054 · DOI · Paper page
- American Diabetes Association, Type 2 diabetes in children and adolescents. Pediatrics 105, 671–680 (2000). https://doi.org/10.1542/peds.105.3.671 · DOI · Paper page
- S. Srinivasan, L. Chen, J. Todd, J. Divers, S. Gidding, S. Chernausek, R.A. Gubitosi-Klug, M.M. Kelsey, R. Shah, M.H. Black, L.E. Wagenknecht, A. Manning, J. Flannick, G. Imperatore, J.M. Mercader, D. Dabelea, J.C. Florez, The first genome-wide association study for type 2 diabetes in youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium. Diabetes 70, 996–1005 (2021). https://doi.org/10.2337/db20-0443 · DOI · Paper page
- D.J. Pettitt, J.M. Lawrence, J. Beyer, T.A. Hillier, A.D. Liese, B. Mayer-Davis, B. Loots, G. Imperatore, L. Liu, L.M. Dolan, B. Linder, D. Dabelea, Association between maternal diabetes in utero and age at offspring’s diagnosis of type 2 diabetes. Diabetes Care 31, 2126–2130 (2008). https://doi.org/10.2337/dc08-0769 · DOI · Paper page
- N. Martín‐Calvo, L. Goni, J.A. Tur, J.A. Martínez, Low birth weight and small for gestational age are associated with complications of childhood and adolescence obesity: systematic review and meta‐analysis. Obes. Rev. 23, e13380 (2022). https://doi.org/10.1111/obr.13380 · DOI
- B. Fishman, E. Grossman, I. Zucker, O. Orr, M. Lutski, A. Bardugo, C.D. Bendor, Y. Leiba, T. Cukierman-Yaffe, E. Derazne, O. Mosenzon, D. Tzur, Z. Beer, O. Pinhas-Hamiel, T. Fishman, A. Afek, A. Tirosh, I. Raz, H.C. Gerstein, G. Twig, Adolescent hypertension and risk for early-onset type 2 diabetes: a nationwide study of 1.9 million Israeli adolescents. Diabetes Care 44, e6–e8 (2021). https://doi.org/10.2337/dc20-1752 · DOI
- J. Pan, W. Jia, Early-onset diabetes: an epidemic in China. Front. Med. 12, 624–633 (2018). https://doi.org/10.1007/s11684-018-0669-1 · DOI
- T. Reinehr, B. Karges, T. Meissner, S. Wiegand, M. Fritsch, R.W. Holl, J. Woelfle, Fibroblast growth factor 21 and fetuin-a in obese adolescents with and without type 2 diabetes. J. Clin. Endocrinol. Metab. 100, 3004–3010 (2015). https://doi.org/10.1210/jc.2015-2192 · DOI
- B. Valaiyapathi, B. Gower, A.P. Ashraf, Pathophysiology of type 2 diabetes in children and adolescents. Curr. Diabetes Rev. 16, 220–229 (2020). https://doi.org/10.2174/1573399814666180608074510 · DOI
- S. Liu, X. Wang, Q. Zheng, L. Gao, Q. Sun, Sleep deprivation and central appetite regulation. Nutrients 14, 5196 (2022). https://doi.org/10.3390/nu14245196 · DOI
- A. Serbis, V. Giapros, K. Tsamis, F. Balomenou, A. Galli-Tsinopoulou, E. Siomou, Beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients. Nutrients 15, 2217 (2023). https://doi.org/10.3390/nu15092217 · DOI
- T. Barrett, M.Y. Jalaludin, S. Turan, M. Hafez, N. Shehadeh, Rapid progression of type 2 diabetes and related complications in children and young people—A literature review. Pediatr. Diabetes 21, 158–172 (2020). https://doi.org/10.1111/pedi.12953 · DOI
- Y. Wu, C. Liu, H. Sun, A. Vijayakumar, P.R. Giglou, R. Qiao, J. Oppenheimer, S. Yakar, D. Leroith, Growth hormone receptor regulates β cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J. Clin. Investig. 121, 2422–2426 (2011). https://doi.org/10.1172/JCI45027DS1 · doi:10.1172/jci45027ds1
- C. Brufani, A. Grossi, D. Fintini, A. Tozzi, V. Nocerino, P.I. Patera, G. Ubertini, O. Porzio, F. Barbetti, M. Cappa, Obese children with low birth weight demonstrate impaired β-cell function during oral glucose tolerance test. J. Clin. Endocrinol. Metab. 94, 4448–4452 (2009). https://doi.org/10.1210/jc.2009-1079 · DOI
- R. Singh, E. Pearson, P.J. Avery, M.I. McCarthy, J.C. Levy, G.A. Hitman, M. Sampson, M. Walker, A.T. Hattersley, Reduced beta cell function in offspring of mothers with young-onset type 2 diabetes. Diabetologia 49, 1876–1880 (2006). https://doi.org/10.1007/s00125-006-0285-5 · DOI
- F.A. Van Assche, F. De Prins, L. Aerts, M. Verjans, The endocrine pancreas in small-for-dates infants. Br. J. Obstet. Gynaecol. 84, 751–753 (1977). https://doi.org/10.1111/j.1471-0528.1977.tb12486.x · DOI · Paper page
- R. Weiss, S. Caprio, M. Trombetta, S.E. Taksali, W.V. Tamborlane, R. Bonadonna, β-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54, 1735–1743 (2005). https://doi.org/10.2337/diabetes.54.6.1735 · DOI · Paper page
- P. Zeitler, L. El Ghormli, S. Arslanian, S. Caprio, E. Isganaitis, M.K. Kelsey, R.S. Weinstock, N.H. White, K. Drews, Deterioration of glycemic control in youth-onset type 2 diabetes: what are the early and late predictors? J. Clin. Endocrinol. Metab. 107, E3384–E3394 (2022). https://doi.org/10.1210/clinem/dgac254 · DOI
- Y. Guo, M. Traurig, L. Ma, S. Kobes, I. Harper, A.M. Infante, C. Bogardus, L.J. Baier, M. Prochazka, CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes 55, 3625–3629 (2006). https://doi.org/10.2337/db06-0379 · DOI
- C. Cropano, N. Santoro, L. Groop, C.D. Man, C. Cobelli, A. Galderisi, R. Kursawe, B. Pierpont, M. Goffredo, S. Caprio, The rs7903146 variant in the tcf7l2 gene increases the risk of prediabetes/type 2 diabetes in obese adolescents by impairing b-cell function and hepatic insulin sensitivity. Diabetes Care 40, 1082–1089 (2017). https://doi.org/10.2337/dc17-0290 · DOI
- D.F. De Jesus, Z. Zhang, S. Kahraman, N.K. Brown, M. Chen, J. Hu, M.K. Gupta, C. He, R.N. Kulkarni, m6A mRNA methylation regulates human β-cell biology in physiological states and in type 2 diabetes. Nat. Metab. 1, 765–774 (2019). https://doi.org/10.1038/s42255-019-0089-9 · DOI · Paper page
- M. Ma, T. Jiang, D. Zhang, X. Yao, Z. Wen, L. Xiu, Association of bedtime with early-onset diabetes and islet beta cell function in patients with newly diagnosed type 2 diabetes mellitus. Nat. Sci. Sleep 15, 653–662 (2023). https://doi.org/10.2147/NSS.S413992 · DOI
- A. Zajec, K. Trebušak Podkrajšek, T. Tesovnik, R. Šket, B. Čugalj Kern, B. Jenko Bizjan, D. Šmigoc Schweiger, T. Battelino, J. Kovač, Pathogenesis of type 1 diabetes: established facts and new insights. Genes 13, 706 (2022). https://doi.org/10.3390/genes13040706 · DOI
- A. Khadilkar, C. Oza, S.A. Mondkar, Insulin resistance in adolescents and youth with type 1 diabetes: a review of problems and solutions. Clin. Med. Insights Endocrinol. Diabetes 16, 11795514231206730 (2023). https://doi.org/10.1177/11795514231206730 · DOI
- H. Baek, J.-Y. Park, J. Yu, J. Lee, Y. Yang, J. Ha, S.H. Lee, J.H. Cho, D.-J. Lim, H.-S. Kim, Characteristics of glycemic control and long-term complications in patients with young-onset type 2 diabetes. Endocrinol. Metab. 37, 641–651 (2022). https://doi.org/10.3803/EnM.2022.1501 · DOI
- N.A. ElSayed, G. Aleppo, V.R. Aroda, R.R. Bannuru, F.M. Brown, D. Bruemmer, B.S. Collins, J.L. Gaglia, M.E. Hilliard, D. Isaacs, E.L. Johnson, S. Kahan, K. Khunti, J. Leon, S.K. Lyons, M.Lou Perry, P. Prahalad, R.E. Pratley, J.J. Seley, R.C. Stanton, R.A. Gabbay, 2. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes Care 46, S19–S40 (2023). https://doi.org/10.2337/dc23-S002 · DOI · Paper page
- R. Unnikrishnan, V.N. Shah, V. Mohan, Challenges in diagnosis and management of diabetes in the young. Clin. Diabetes Endocrinol. 2, 18 (2016). https://doi.org/10.1186/s40842-016-0036-6 · DOI
- M. Tosur, L.H. Philipson, Precision diabetes: lessons learned from maturity‐onset diabetes of the young (MODY). J. Diabetes Investig. 13, 1465–1471 (2022). https://doi.org/10.1111/jdi.13860 · DOI
- R.P. Brady, A.S. Shah, E.T. Jensen, J.M. Stafford, R.B. D’Agostino, L.M. Dolan, L. Knight, G. Imperatore, C.B. Turley, A.D. Liese, E.M. Urbina, J.M. Lawrence, C. Pihoker, S. Marcovina, D. Dabelea, Glycemic control is associated with dyslipidemia over time in youth with type 2 diabetes: The SEARCH for Diabetes in Youth Study. Pediatr. Diabetes 22, 951–959 (2021). https://doi.org/10.1111/pedi.13253 · DOI
- L. Wang, N. Yan, M. Zhang, R. Pan, Y. Dang, Y. Niu, The association between blood glucose levels and lipids or lipid ratios in type 2 diabetes patients: a cross-sectional study. Front. Endocrinol. 13, 969080 (2022). https://doi.org/10.3389/fendo.2022.969080 · DOI
- N. Nanayakkara, A.J. Curtis, S. Heritier, A.M. Gadowski, M.E. Pavkov, T. Kenealy, D.R. Owens, R.L. Thomas, S. Song, J. Wong, J.C.-N. Chan, A.O.-Y. Luk, G. Penno, L. Ji, V. Mohan, A. Amutha, P. Romero-Aroca, D. Gasevic, D.J. Magliano, H.J. Teede, J. Chalmers, S. Zoungas, Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 64, 275–287 (2021). https://doi.org/10.1007/s00125-020-05319-w · DOI · Paper page
- L. Huo, D.J. Magliano, F. Rancière, J.L. Harding, N. Nanayakkara, J.E. Shaw, B. Carstensen, Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011. Diabetologia 61, 1055–1063 (2018). https://doi.org/10.1007/s00125-018-4544-z · DOI · Paper page
- I. Lerman-Garber, D. Cuevas-Ramos, S. Valdés, L. Enríquez, M. Lobato, M. Osornio, A.R. Escobedo, V. Pascual-Ramos, R. Mehta, J. Ramírez-Anguiano, F.J. Gómez-Pérez, Sensorineural hearing loss-a common finding in early-onset type 2 diabetes me llitus. Endocr. Pract. 18, 549–557 (2012). https://doi.org/10.4158/EP11389.OR · DOI
- A. Bener, A.A. Al-Ansari, M. Zirie, A.O.A.A. Al-Hamaq, Is male fertility associated with type 2 diabetes mellitus? Int. Urol. Nephrol. 41, 777–784 (2009). https://doi.org/10.1007/s11255-009-9565-6 · DOI
- B.K. Riaz, S. Selim, M. Neo, M.N. Karim, M.M. Zaman, Risk of depression among early onset type 2 diabetes mellitus patients. Dubai Diabetes Endocrinol. J. 27, 55–65 (2021). https://doi.org/10.1159/000515683 · DOI · Paper page
- Y. Cho, H.-S. Park, B.W. Huh, S.H. Seo, D.H. Seo, S.H. Ahn, S. Hong, Y.J. Suh, S.H. Kim, Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus. Diabetes Metab. 48, 101389 (2022). https://doi.org/10.1016/j.diabet.2022.101389 · DOI
- A.H. Al-Saeed, M.I. Constantino, L. Molyneaux, M. D’Souza, F. Limacher-Gisler, C. Luo, T. Wu, S.M. Twigg, D.K. Yue, J. Wong, An Inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care 39, 823–829 (2016). https://doi.org/10.2337/dc15-0991 · DOI · Paper page
- R. Unnikrishnan, R.M. Anjana, A. Amutha, H. Ranjani, S. Jebarani, M.K. Ali, K. Narayan, V. Mohan, Younger-onset versus older-onset type 2 diabetes: clinical profile and complications. J. Diabetes Complications 31, 971–975 (2017). https://doi.org/10.1016/j.jdiacomp.2017.03.007 · DOI
- L. Huang, P. Wu, Y. Zhang, Y. Lin, X. Shen, F. Zhao, S. Yan, Relationship between onset age of type 2 diabetes mellitus and vascular complications based on propensity score matching analysis. J. Diabetes Investig. 13, 1062–1072 (2022). https://doi.org/10.1111/jdi.13763 · DOI
- D. Dabelea, J.M. Stafford, E.J. Mayer-Davis, R. D’Agostino, L. Dolan, G. Imperatore, B. Linder, J.M. Lawrence, S.M. Marcovina, A.K. Mottl, M.H. Black, R. Pop-Busui, S. Saydah, R.F. Hamman, C. Pihoker, Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 317, 825 (2017). https://doi.org/10.1001/jama.2017.0686 · DOI · Paper page
- A.S. Shah, S. Isom, R. D’Agostino, L.M. Dolan, D. Dabelea, G. Imperatore, A. Mottl, E. Lustigova, C. Pihoker, S. Marcovina, E.M. Urbina, Longitudinal changes in arterial stiffness and heart rate variability in youth-onset type 1 versus type 2 diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care 45, 1647–1656 (2022). https://doi.org/10.2337/dc21-2426 · DOI
- M.C. Eppens, M.E. Craig, J. Cusumano, S. Hing, A.K.F. Chan, N.J. Howard, M. Silink, K.C. Donaghue, Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29, 1300–1306 (2006). https://doi.org/10.2337/dc05-2470 · DOI · Paper page
- S.H. Song, Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population. BMJ Open Diabetes Res. Care 3, e000044 (2015). https://doi.org/10.1136/bmjdrc-2014-000044 · DOI · Paper page
- J.A. Sargeant, E.M. Brady, F. Zaccardi, F. Tippins, D.R. Webb, V.R. Aroda, E.W. Gregg, K. Khunti, M.J. Davies, Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials. Diabetologia 63, 1516–1520 (2020). https://doi.org/10.1007/s00125-020-05174-9 · DOI · Paper page
- K.-T. Kao, M.A. Sabin, Type 2 diabetes mellitus in children and adolescents. Aust. Fam. Physician 45, 401–406 (2016)
- G. Rao, E.T. Jensen, Type 2 diabetes in youth. Glob. Pediatr. Health 7, 2333794X2098134 (2020). https://doi.org/10.1177/2333794X20981343 · DOI
- J.L. Miller, J.H. Silverstein, The management of type 2 diabetes mellitus in children and adolescents. J. Pediatr. Endocrinol. Metab. 18, 111–123 (2005). https://doi.org/10.1515/JPEM.2005.18.2.111 · DOI
- A. Herbst, T. Kapellen, E. Schober, C. Graf, T. Meissner, R. Holl, Impact of regular physical activity on blood glucose control and cardiovascular risk factors in adolescents with type 2 diabetes mellitus - a multicenter study of 578 patients from 225 centres. Pediatr. Diabetes 16, 204–210 (2015). https://doi.org/10.1111/pedi.12144 · DOI
- H.K. Jensen, L. Rasmussen, K. Furu, Ø. Karlstad, M. Linder, C.E. Cesta, A. Pottegård, Use of non‐insulin antidiabetic drugs in children and young adults—A Scandinavian drug utilization study from 2010–2019. Br. J. Clin. Pharmacol. 87, 4470–4475 (2021). https://doi.org/10.1111/bcp.14867 · DOI
- TODAY Study Group, A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes. N. Engl. J. Med. 366, 2247–2256 (2012). https://doi.org/10.1056/NEJMoa1109333 · DOI · Paper page
- G.J. Klingensmith, L. Pyle, K.J. Nadeau, L.A. Barbour, R.S. Goland, S.M. Willi, B. Linder, N.H. White, Pregnancy outcomes in youth with type 2 diabetes: the TODAY study experience. Diabetes Care 39, 122–129 (2016). https://doi.org/10.2337/dc15-1206 · DOI · Paper page
- G. Mingrone, Pros and cons of bariatric surgery in adolescents. Lancet Diabetes Endocrinol. 5, 152–154 (2017). https://doi.org/10.1016/S2213-8587(16)30425-9 · DOI
- Y. Hu, L. Li, J. Zhang, Diabetes distress in young adults with type 2 diabetes: a cross-sectional survey in China. J. Diabetes Res. 2020, 1–6 (2020). https://doi.org/10.1155/2020/4814378 · DOI · Paper page
- P.M. Trief, D. Uschner, S. Kalichman, B.J. Anderson, L.M. Fette, H. Wen, J.D. Bulger, R.S. Weinstock, Psychosocial factors predict medication adherence in young adults with youth‐onset type 2 diabetes: longitudinal results from the TODAY2 iCount study. Diabet. Med. 40, e15062 (2023). https://doi.org/10.1111/dme.15062 · DOI
- M. Carino, Z. Quill, M. Gabbs, E. Sellers, J. Hamilton, T. Pinto, M. Jetha, J. Ho, O.G. Alecio, A. Dart, B. Wicklow, Impact of COVID-19 pandemic on adolescents and young adults living with type 2 diabetes. Can. J. Diabetes 46, 404–410 (2022). https://doi.org/10.1016/j.jcjd.2022.01.002 · DOI
Cited by
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031094 · Cited by 328
Cha, E., Son, N.-H., Huh, Y. E., Jang, H., Park, H., Sung, G., Kim, G., Baek, G., Kim, J., Shin, Y.-A., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108132 · Cited by 4
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Strati, M., Moustaki, M., Psaltopoulou, T., Vryonidou, A., & Paschou, S. A.
- Venue
- Endocrine
- Published
- 2024-03-12
- Volume
- 85
- Issue
- 3
- Pages
- 965-978
- ISSN
- 1559-0100
- Cited by
- 148
- References
- 26
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early onset type 2 diabetes mellitus: an update. https://app.cochat.ai/papers/10.1007/s12020-024-03772-w
- The paper
- Strati, M., Moustaki, M., Psaltopoulou, T., Vryonidou, A., & Paschou, S. A. (2024). Early onset type 2 diabetes mellitus: an update. Endocrine. https://doi.org/10.1007/s12020-024-03772-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.